Welcome to our dedicated page for NuSkin Enterprises news (Ticker: NUS), a resource for investors and traders seeking the latest updates and insights on NuSkin Enterprises stock.
Nu Skin Enterprises, Inc. (NYSE: NUS) is a global leader in health and beauty, founded 35 years ago. The company excels in creating and distributing innovative consumer products, focusing on beauty and wellness. Nu Skin’s product lines include personal care items under the Nu Skin brand and nutritional supplements marketed under the Pharmanex brand. Operating in more than 50 countries, the firm’s extensive reach reflects its robust international presence.
Nu Skin Enterprises encompasses several companies such as Nu Skin, Groviv, Wasatch Labs, Elevate Health Sciences, and Casepak. This diverse portfolio enables the company to offer a wide range of products and services, from consumer goods to advanced manufacturing and controlled environment agriculture technologies.
In recent developments, Nu Skin has shown a commitment to innovation and growth. In October 2023, the company announced the release of its third quarter financial results, revealing both challenges and growth opportunities. Despite economic hurdles, particularly in Mainland China and the Americas, Nu Skin experienced stabilization and growth in regions like Europe and Africa. The introduction of new products, such as the ageLOC® WellSpa iO™ and an upcoming mental wellness category in 2024, showcases the firm’s dedication to expanding its offerings and driving long-term success.
In November 2023, Nu Skin celebrated the opening of a new manufacturing facility in Shanghai, China, an investment of approximately $55 million. This facility exemplifies the company's commitment to enhancing production capacity and supply chain efficiency, particularly in Asian markets. The plant uses Industry 4.0 standards, featuring smart systems and real-time data analysis, further underlining Nu Skin’s focus on technological advancement and sustainability.
Additionally, in February 2024, Nu Skin introduced the RenuSpa iO, a smart device designed to promote skin health and body confidence. This FDA-cleared device embodies the latest in microcurrent technology, offering personalized beauty and wellness solutions. The Nu Skin Vera® app enhances the user experience by providing real-time data insights and guided tutorials.
Financial Overview: As of the latest updates, Nu Skin’s projected 2023 revenue is between $1.92 and $1.96 billion, with an expected EPS of $(0.10) to $0.05 or adjusted EPS of $1.62 to $1.77, excluding significant charges. The company’s strategic initiatives, including cost management and product portfolio optimization, aim to drive future growth and profitability.
Nu Skin Enterprises (NYSE: NUS) announced its acquisition of Mavely, a social commerce platform that enhances customer acquisition and social selling. This strategic move aims to empower Nu Skin affiliates to better share and sell products, tapping into the expected $3.4 trillion social commerce market by 2028. The integration of Mavely's technology is anticipated to boost Nu Skin's growth, offering innovative digital tools for a more effective shopping experience. Mavely will operate under Rhyz, Nu Skin's investment arm, continuing its mission in empowering social sellers.
Nu Skin Enterprises reported Q3 2021 revenue of $641.2 million, a 9% decline year-over-year, with EPS of $0.97, down 10%. The decrease was primarily due to COVID-19 disruptions, particularly in China and Southeast Asia, affecting sales initiatives. Despite challenges, the U.S. market showed growth, notably with the launch of Beauty Focus Collagen+. For Q4, revenue is projected between $645 and $675 million, and EPS is expected at $0.90 to $1.00.
The full-year revenue forecast remains at $2.67 to $2.70 billion, anticipating a 3% to 5% growth.
Nu Skin Enterprises (NYSE: NUS) declared a quarterly cash dividend of $0.38 per share, set to be paid on December 8, 2021. Shareholders on record as of November 26, 2021 will receive this payment. The company focuses on beauty and wellness, leveraging over 35 years of scientific research to develop innovative personal care and nutritional products globally. Nu Skin is committed to sustainability, including reducing packaging waste by 2030. The announcement affirms the company’s ongoing financial health and dedication to rewarding shareholders.
Rhyz Analytical Labs launched analytical testing services for beauty and wellness companies to ensure product safety and effectiveness. Located in Provo, Utah, the lab combines expert scientists with advanced technology to deliver timely, accurate results for foods, dietary supplements, and cosmetics. The company is ISO 17025:2017 accredited and provides a range of testing services including shelf-life testing and microbiological assessments. As part of Nu Skin Enterprises (NYSE: NUS), Rhyz aims to support the entire supply chain for its partners.
Nu Skin Enterprises (NUS) estimates its third-quarter revenue between $637 million and $642 million, lower than expected due to COVID-19 disruptions, particularly in Mainland China and Southeast Asia. CEO Ryan Napierski noted that unanticipated government restrictions impacted sales and promotional activities. Despite these challenges, the launch of Collagen+ in the U.S. contributed to growth, and the company is optimistic about future product launches and social commerce tools. Full third-quarter results will be shared on November 3.
Nu Skin Enterprises reported Q2 2021 revenue of $704.1 million, a 15% increase compared to the prior year, with earnings per share (EPS) of $1.15, up 42%. The growth was attributed to a 260 basis point increase in operating margin, driven by improved profitability and digital commerce advancements. Internationally, sales leaders grew by 15%, while customer numbers saw a 2% decline. Looking ahead, the company projects Q3 revenue between $700-$730 million with EPS of $1.10-$1.20, and is focused on enhancing shareholder value.
Nu Skin Enterprises declared a quarterly cash dividend of $0.38 per share, set for payment on Sept. 8, 2021. Shareholders of record by Aug. 27, 2021 will receive this dividend. Founded over 35 years ago, Nu Skin focuses on innovative consumer products and sustainable solutions, operating globally across various regions including Asia, the Americas, Europe, Africa, and the Pacific. The company is listed on the NYSE under the symbol NUS.
Nu Skin (NYSE: NUS) hosted its annual Force for Good Day on July 7, 2021, focusing on humanitarian efforts for at-risk children worldwide. This year, employees and affiliates participated in local service projects, creating 2,600 educational items. Global initiatives included food drives in Japan and gift boxes for low-income families in Korea. The company aims to inspire its affiliates and community to support children in need, reflecting its commitment to social responsibility.
FAQ
What is the current stock price of NuSkin Enterprises (NUS)?
What is the market cap of NuSkin Enterprises (NUS)?
What does Nu Skin Enterprises, Inc. do?
When was Nu Skin Enterprises, Inc. founded?
What is the ticker symbol for Nu Skin Enterprises, Inc.?
What were the recent financial results for Nu Skin Enterprises, Inc.?
What is the ageLOC® WellSpa iO™?
What is the significance of the new manufacturing facility in China for Nu Skin?
What is RenuSpa iO?
Who are the members of the Nu Skin Enterprises family?
How does Nu Skin contribute to sustainability?
What is the Nu Skin Vera® app?
